Close Menu


Quest's management, including CEO Steve Rusckowski, will take temporary pay cuts, while rank-and-file employees may be furloughed or have their overtime reduced.

MicroGen Dx's Texas-based lab is the only commercial laboratory in the US offering sputum testing for SARS-CoV-2.

This week Quest Diagnostics said it saw declines of more than 40 percent while other industry observers reported drops of as much as 90 percent for some labs.

Such tests indicate whether a person had an immune response to the virus, which could aid infection tracking and identifying individuals with immunity.

The company has said it expects to be able to perform roughly 10,000 tests a day by the end of this week and roughly 20,000 tests per day by the end of March.

In announcing a national emergency on Friday, Trump paraded out executives from the private sector as the administration tries to increase testing capacity

Firms like LabCorp, Quest, and BioReference have launched tests but a lack of clarity around demand presents challenges for assessing what capacity is needed.

LabCorp's test is being made available pursuant to FDA guidance that allows high-complexity, CLIA-certified labs to perform their own tests for SARS-CoV-2.

Quest and LabCorp recently highlighted increased compensation costs while other industry observers have seen salaries rising for specialties like molecular.

Following a lengthy discovery period, the lab is asking a South Carolina federal district court to find in its favor and decide that its negligence did not result in the death of Williams' son.